Abstract
The article discusses the use of the type 2 novel oral poliovirus vaccine against the type 2 circulating vaccine-derived poliovirus outbreak in Tajikistan in 2020-2021. Other topics include the identification by the Regional Reference Laboratory (RRL) for polio in Russia of a specimen from a Tajikistani patient with acute flaccid paralysis (AFP) and the RRL result showing a 20-nucleotide divergence of the isolate from the Sabin vaccine virus strain.
Cite
CITATION STYLE
O’Connor, P., Huseynov, S., Nielsen, C. F., Saidzoda, F., Saxentoff, E., Sadykova, U., & Kormoss, P. (2022). Notes from the Field: Readiness for Use of Type 2 Novel Oral Poliovirus Vaccine in Response to a Type 2 Circulating Vaccine-Derived Poliovirus Outbreak — Tajikistan, 2020–2021. MMWR. Morbidity and Mortality Weekly Report, 71(9), 361–362. https://doi.org/10.15585/mmwr.mm7109a4
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
